In the field of molecular biology and biochemical research, the interaction between the BirA enzyme and specific peptide sequences has become a gold standard for site-specific labeling. As a researcher who frequently engages with high-precision protein modification tools, I have found that mastering the nuances of the BirA peptide systems—specifically those utilizing the AviTag—is essential for achieving consistent, reliable results in *in vitro* applications.
The Nature of the BirA Enzyme
The BirA biotin-protein ligase is a fascinating 35 kDa bacterial A bifunctional protein that exhibits biotin ligase activity and also acts as the DNA binding transcriptional repressor of the biotin operon. protein derived from *Escherichia coli*. My experience with this enzyme confirms that it is a bifunctional protein of remarkable utility. It acts both as a biotin--[acetyl-CoA-carboxylase] ligase and a biotin-operon repressor. This dual functionality is encoded by the *birA* gene, which regulates biotin synthesis while simultaneously performing the critical task of post-translational modification.
When working with purified His6-BirA, I have observed that the enzyme exhibits biotin ligase activity with high specificity. It functions by activating biotin in the presence of ATP to form a biotinyl-5'-adenylate inte p06709 · bira_ecoli rmediate, which is then transferred to a specific lysine residue within a defined acceptor peptide sequence.
The Role of the AviTag Peptide
The most common application involves the AviTag, a 15-amino acid sequence that serves as the target for the BirA enzyme. Through my own laboratory practices, I have noted that the BirA is able to link biotin to the lysine residue of the Avi tag with exceptional efficiency.
This process is often facilitated by BirA biotin-protein ligase kits, which provide the necessary buffers and optimized concentrations to ensure the reaction proceeds to completion. Whether you are performing site-specific attachment to recombinant proteins or utilizing a BirA* enzyme (a mutant form often used for proximity labeling), t by Y Li · 2012 · Cited by 24 — BirA is a biotin ligase from Escherichia coli that specifically biotinylates a lysine side-chain within a 15-amino acid acceptor peptide (also known as Avi-tag) he precision of this system is unm Recombinant E. coli BirA protein (Active) (His-DDDDK tag atched.
Practical Considerations for Research
For those looking to integrate this into their workflows, here are several key takeaways based on technical data and personal observations:
* Enzymatic Specificity: Biotinylation is mediated by the enzyme BirA biotin ligase, which recognizes the specific motif rather than the entire protein structure. This minimizes the risk of off-target labeling.
* Experimental Efficiency: When using Active Recombinant E. coli BirA protein, I recommend strictly adhering to temperature and incubation time protocols. In my experience, even minor deviations in the buffer composition can affect the kinetics of the reaction.
* System Versatility: Because BirA is a biotin ligase from Escherichia coli, it is highly robust in various buffe by E de Boer · 2003 · Cited by 564 — We expressed the bacterial BirA biotin ligase in mammalian cells and demonstrated very efficient biotinylation of a hematopoietic transcription factor bearing a r systems. However, always ensure your target protein is correctly folded to expose the AviTag sequence.
* Troubleshooting: If you are seeking tips for using pMal-T-Avi-His/BirA, ensure that your expression system is well-calibrated. Using the right bacterial strain, such as those optimized for protein solubility, can significantly improve th Recombinant BirA protein, His-Tag e yield of your biotinylated product.
Conclusion
The Biotin-protein ligase sys by LT Oostdyk · 2018 · Cited by 21 — Proximity labeling by BirA fused to proteins of interest can be modulated by amino acid substitutions that affect biotin affinity and the release of biotinyl-5 tem represents a cornerstone of modern biotechnology. By understanding that Biotin ligase (BirA) acts with such distinct biochemical precision, researchers can reliably modify proteins for a variety of analytical tasks. Whether you are using a commercial BirA Biotin-protein ligase kit or purifying your own enzyme, the ability to use to label the AviTag target remains one of the most effective methods for site-specific protein engineering. Having navigated these protocols multiple times, I can attest that the stability and specificity of the BirA system make it an indispensable tool for those requiring high-quality, labeled peptide constructs.